You just read:

Positive Results Presented from Two Phase 3 Trials of Dupixent® (dupilumab) in Severe Chronic Rhinosinusitis with Nasal Polyps (CRSwNP)

News provided by

Regeneron Pharmaceuticals, Inc.

Feb 25, 2019, 12:44 ET